Novel antibody targets and eliminates human acute myeloid leukemic stem cells in preclinical models. [ + ]

A prominent international researcher working at the interface between obesity and depression has been appointed to lead the John Curtin School of Medical Research at The Australian National University.

New research on microRNAs holds promise for diagnosing and treating diseases in blood vessels. [ + ]

Cochlear, Healthscope, Blackmores, Ramsey, CSL, ResMed [ + ]

Handheld medical diagnostic system inventor, Micah Atkin, wins INNOVIC’s 2009 International Next Big Thing Award. [ + ]

Bacteriologist Elizabeth Harry revolutionised her field by working out a better way to watch bacteria do their thing. And what she found was more than she ever expected. [ + ]

Embryonic stem cells and induced pluripotent stem cells have been found to have inherent molecular differences, making it possible to clearly distinguish between the two cell types.

Living Cell Technologies opens pig breeding facility ahead of xenotransplantation trials to treat type 1 diabetes. [ + ]

Cochlear, Ramsay, ResMed, Biota, Ansell [ + ]

Australian researchers find that interfering RNA delivered via bacterially-derived minicells can target and kill drug resistant tumours. [ + ]

Patrys Limited (ASX:PAB) announces a renounceable pro-rata rights issue to eligible shareholders. [ + ]

The University of Queensland's Australian Institute for Bioengineering and Nanotechnology has created a vaccine matched to the virus found in the first US case of swine flu.

New technology is allowing us to probe the dark matter of the genome, providing further evidence for John Mattick’s no-longer controversial argument that much of the genome, previously thought to be junk DNA, actually codes for a vast network of regulatory RNAs. [ + ]

ResMed, CSL, Biota, Sonic Healthcare, ChemGenex, Sirtex [ + ]

Adult muscle stem cells rather than embryonic stem cells could be the key to treating muscular disorders. [ + ]